Position in HALO
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$457,488
+$221,589 QoQ
Shares Held
5,845
+60.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#402
of 664 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026StoneX Group Inc. holds $4,702,554 across 49 Biotechnology names. HALO ranks #4 (9.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,066 | $1,026,244 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
891 | $555,574 | |
| 3 | PRAX |
Praxis Precision Medicines, Inc.
|
1,521 | $509,215 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
This page
|
5,845 | $457,488 | |
| 5 | HRMY |
Harmony Biosciences Holdings, Inc.
|
12,149 | $442,345 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
3,888 | $289,578 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
4,133 | $225,413 | |
| 8 | REPL |
Replimune Group, Inc.
|
10,770 | $119,223 |
All Filings in HALO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $457,488 | 5,845 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $235,899 | 3,650 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $245,645 | 3,650 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $258,010 | 3,518 | Shares | Defined | 2025-11-14 | |
| 2025-03-31 | $276,871 | 4,339 | Shares | Defined | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||